The FDA approved epcoritamab-bysp in combination with lenalidomide and rituximab for patients with relapsed or refractory ...

A newly approved blood test can help rule out some cases based on the amount of amyloid in the brain. A neurology professor ...

The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).

The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...

Plozasiran is the first FDA-approved drug for familial chylomicronemia syndrome, reducing triglycerides as an adjunct to diet ...

There is a new FDA-approved eye drop on the market called Vizz. This once-daily, prescription eye drop is said to help combat presbyopia, otherwise known as age-related blurry vision. Drugmaker Lenz ...

U.S. Senators Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen (D-N.H.) today introduced the Non-Opioids Prevent Addiction ...

A recent analysis reveals that monthly prices of checkpoint inhibitors decreased only a small amount over a decade.

The top-line data from the first cohort demonstrate a favorable safety profile, with no serious adverse events reported and the treatment generally well-tolerated across all participants. Additionally ...

UNC School of Medicine researchers have led an international clinical trial of patients with generalized myasthenia gravis, finding the therapy is safe and effective across all subtypes.

The FDA has approved daratumumab and hyaluronidase-fihj monotherapy as treatment for adults with high-risk smoldering ...